A Highly Productive CHO Cell Line Secreting Human Blood Clotting Factor IX

Hemophilia B patients suffer from an inherited blood-clotting defect and require regular administration of blood-clotting factor IX replacement therapy. Recombinant human factor IX produced in cultured CHO cells is nearly identical to natural, plasma-derived factor IX and is widely used in clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovnir, S. V., Orlova, N. A., Shakhparonov, M. I., Skryabin, K. G., Gabibov, A. G., Vorobiev, I. I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: A.I. Gordeyev 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916734/
https://www.ncbi.nlm.nih.gov/pubmed/29713519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916734/
https://www.ncbi.nlm.nih.gov/pubmed/29713519

Ejemplares similares